MAPT and Alzheimer disease: SkQ1 increased behavioral activity, and reduced destructive changes in mitochondria, pathological accumulation of AβPP, Aβ, hyperphosphorylation of tau-protein and hippocampal Aβ40 and Aβ42 protein levels in AD model rats [129,130].